Timpani Capital Management LLC cut its stake in shares of Tactile Systems Technology Inc (NASDAQ:TCMD) by 20.2% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 43,911 shares of the company’s stock after selling 11,104 shares during the period. Timpani Capital Management LLC owned 0.23% of Tactile Systems Technology worth $2,315,000 as of its most recent filing with the SEC.
A number of other hedge funds and other institutional investors also recently modified their holdings of the stock. NumerixS Investment Technologies Inc lifted its stake in shares of Tactile Systems Technology by 240.0% during the 4th quarter. NumerixS Investment Technologies Inc now owns 1,700 shares of the company’s stock valued at $75,000 after buying an additional 1,200 shares in the last quarter. Neuburgh Advisers LLC increased its holdings in shares of Tactile Systems Technology by 22.2% in the 4th quarter. Neuburgh Advisers LLC now owns 1,760 shares of the company’s stock worth $80,000 after buying an additional 320 shares during the last quarter. BerganKDV Wealth Management LLC bought a new stake in shares of Tactile Systems Technology in the 1st quarter worth about $158,000. LS Investment Advisors LLC increased its holdings in shares of Tactile Systems Technology by 580.2% in the 4th quarter. LS Investment Advisors LLC now owns 3,639 shares of the company’s stock worth $166,000 after buying an additional 3,104 shares during the last quarter. Finally, BNP Paribas Arbitrage SA increased its holdings in shares of Tactile Systems Technology by 73,060.0% in the 1st quarter. BNP Paribas Arbitrage SA now owns 3,658 shares of the company’s stock worth $193,000 after buying an additional 3,653 shares during the last quarter. 99.65% of the stock is owned by hedge funds and other institutional investors.
In related news, COO Robert J. Folkes sold 2,500 shares of the firm’s stock in a transaction dated Thursday, April 18th. The shares were sold at an average price of $49.83, for a total transaction of $124,575.00. Following the completion of the sale, the chief operating officer now directly owns 111,654 shares in the company, valued at $5,563,718.82. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Kevin H. Roche sold 4,907 shares of the firm’s stock in a transaction dated Thursday, May 30th. The stock was sold at an average price of $50.00, for a total transaction of $245,350.00. Following the sale, the director now owns 40,311 shares of the company’s stock, valued at $2,015,550. The disclosure for this sale can be found here. Over the last three months, insiders sold 50,019 shares of company stock worth $2,719,711. Insiders own 6.50% of the company’s stock.
Shares of NASDAQ TCMD opened at $51.66 on Wednesday. Tactile Systems Technology Inc has a 1 year low of $37.40 and a 1 year high of $76.63. The firm has a market cap of $989.85 million, a P/E ratio of 151.94, a PEG ratio of 5.29 and a beta of 1.96. The company has a current ratio of 4.96, a quick ratio of 4.30 and a debt-to-equity ratio of 0.03.
Tactile Systems Technology (NASDAQ:TCMD) last announced its quarterly earnings results on Monday, May 6th. The company reported $0.08 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of ($0.12) by $0.20. The firm had revenue of $37.60 million for the quarter, compared to the consensus estimate of $33.30 million. Tactile Systems Technology had a net margin of 5.27% and a return on equity of 8.17%. Tactile Systems Technology’s revenue for the quarter was up 40.3% compared to the same quarter last year. On average, research analysts anticipate that Tactile Systems Technology Inc will post 0.5 EPS for the current year.
Tactile Systems Technology Profile
Tactile Systems Technology, Inc, a medical technology company, develops and provides medical devices for the treatment of chronic diseases in the United States. The company offers Flexitouch system, an at-home solution for lymphedema patients; and ACTitouch system, a home-based solution for chronic venous insufficiency patients.
Featured Story: What is dividend yield?
Receive News & Ratings for Tactile Systems Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tactile Systems Technology and related companies with MarketBeat.com's FREE daily email newsletter.